Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic Syndromes

Area of Science:

• Hematology
• Cytogenetics
• Cancer Biology

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• Chromosome abnormalities are common in MDS and are associated with prognosis.
• Understanding the cellular origin and lineage involvement in MDS is critical for diagnosis and treatment.

Purpose of the Study:

• To investigate the specific cell lineages affected by karyotypic abnormalities in patients with myelodysplastic syndrome (MDS).
• To simultaneously analyze the karyotype and immunophenotype of individual mitotic cells in MDS patients.
• To determine the extent of multi-lineage involvement in MDS with chromosomal aberrations.

Main Methods:

• Employed a combined method for simultaneous karyotype and immunophenotype analysis of mitotic cells.
• Utilized monoclonal antibodies in alkaline phosphatase-antialkaline phosphatase (APAAP) staining to identify cell lineages.
• Studied eight patients diagnosed with myelodysplastic syndrome and associated chromosome abnormalities.

Main Results:

• All MDS patients exhibited abnormal karyotypes in cells of the granulocytic/monocytic lineage.
• The leukemic process involved erythrocytic and/or megakaryocytic lineages in 7 out of 8 patients.
• In 4 patients with the 5q- chromosome abnormality, granulocytic/monocytic and erythrocytic lineages showed clonal proliferation; one patient demonstrated a lineage shift.

Conclusions:

• MDS patients with karyotypic abnormalities frequently display multi-lineage involvement.
• The study confirms that chromosomal aberrations in MDS can affect multiple hematopoietic stem cell lineages.
• These findings underscore the complexity of MDS pathogenesis and clonal evolution.